Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SomaLogic, Inc. | Interim CEO | Common Stock | 0 | $2.43 | Jan 5, 2024 | Direct | |
SomaLogic, Inc. | Interim CEO | Restricted Stock Unit | 0 | $2.43 | Jan 5, 2024 | Direct | |
SomaLogic, Inc. | Interim CEO | Stock Option (Right to buy) | 0 | Jan 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TXG | 10x Genomics, Inc. | Aug 12, 2024 | 0 | $0 | 3 | Aug 20, 2024 | Chief Financial Officer |
SLGC | SomaLogic, Inc. | Jan 5, 2024 | 12 | $0 | 4 | Jan 9, 2024 | Interim CEO |
SLGC | SomaLogic, Inc. | Jun 8, 2023 | 2 | $0 | 4 | Jun 12, 2023 | Interim CEO |
SLGC | SomaLogic, Inc. | Mar 28, 2023 | 0 | $0 | 3 | Apr 7, 2023 | Interim CEO |
SLGC | SomaLogic, Inc. | Mar 2, 2023 | 2 | -$53.9K | 4 | Oct 2, 2023 | Interim CEO |